PURITY SPECIFICATIONS, STORAGE, AND DISTRIBUTION FOR MEDICATIONS DEVELOPMENT CONTRACT
药物开发合同的纯度规格、储存和分发
基本信息
- 批准号:10723384
- 负责人:
- 金额:$ 7.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-09 至 2023-07-08
- 项目状态:已结题
- 来源:
- 关键词:ContractorContractsDevelopmentDrug AddictionEnsureEvaluationHelping to End Addiction Long-termInstitutesMedicalNational Institute of Drug AbuseNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeNeurotoxinsPainPain managementPharmaceutical PreparationsPoisonResearchResearch SupportResourcesScheduleSpeedSubstance Abuse DetectionTestingTherapeuticUnited States National Institutes of Healthclinical painprogramsrepositoryresearch and developmentscreening
项目摘要
The Division of Therapeutics and Medical Consequences (DTMC) of the National Institute on Drug Abuse (NIDA)
supports research and development of new medications for the treatment of drug addiction. The objective of this
contract is to provide NIDA and other NIH Institutes (NINDS and NIMH) with a a centralized confidential repository of
compounds for evaluation as potential treatment agents, standards and screening agents.
“This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to understand the basis of pain and enhance clinical pain management.”
美国国家药物滥用研究所(NIDA)治疗和医学后果司
支持研究和开发治疗药物成瘾的新药。这样做的目的是
合同是向NIDA和其他NIH研究所(NINDS和NIMH)提供一个集中的机密存储库
作为潜在处理剂、标准和筛选剂的评估化合物。
这项研究是NIH帮助结束成瘾长期(Hear)倡议的一部分,该倡议旨在加快科学解决方案,以了解疼痛的基础,并加强临床疼痛管理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATIE HAYES其他文献
KATIE HAYES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATIE HAYES', 18)}}的其他基金
NIMH SYNTHESIS AND DISTRIBUTION OF DRUGS OF ABUSE AND RELATED COMPOUNDS. JUNE 16, 2023 - JUNE 15, 2024. TASK ORDER 75N95023F00002 (TO5). N01DA-22-8944.
NIMH 滥用药物及相关化合物的合成和分销。
- 批准号:
10933157 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
SYNTHESIS AND DISTRIBUTION OF DRUGS OF ABUSE AND RELATED COMPOUNDS. JUNE 9, 2023 - JUNE 8, 2024. TASK ORDER 75N95023F00001 (TO4). N01DA-22-8944.
滥用药物及相关化合物的合成和分布。
- 批准号:
10937583 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
PURITY SPECIFICATIONS, STORAGE, AND DISTRIBUTION FOR MEDICATIONS DEVELOPMENT CONTRACT
药物开发合同的纯度规格、储存和分发
- 批准号:
10880210 - 财政年份:2022
- 资助金额:
$ 7.65万 - 项目类别:
PURITY SPECIFICATIONS, STORAGE, AND DISTRIBUTION FOR MEDICATIONS DEVELOPMENT CONTRACT
药物开发合同的纯度规格、储存和分发
- 批准号:
10710586 - 财政年份:2022
- 资助金额:
$ 7.65万 - 项目类别:
PURITY SPECIFICATIONS, STORAGE, AND DISTRIBUTION FOR MEDICATIONS DEVELOPMENT CONTRACT
药物开发合同的纯度规格、储存和分发
- 批准号:
10880211 - 财政年份:2022
- 资助金额:
$ 7.65万 - 项目类别:
PURPOSE: TO AWARD TASK ORDER 2 (PREPARATION AND DISTRIBUTION OF DRUG RESEARCH PRODUCTS) UNDER IDIQ NO. 75N95019D00042 FOR WORK AS DESCRIBED IN THE ATT
目的:授予 IDIQ 编号为 2 的任务令 2(药物研究产品的制备和分发)。
- 批准号:
10286262 - 财政年份:2020
- 资助金额:
$ 7.65万 - 项目类别:
TITLE: ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. BASE PERIOD: POP AUGUST 4, 2019 - AUG
标题:药物使用障碍治疗药物的分析化学和稳定性测试。
- 批准号:
10287524 - 财政年份:2019
- 资助金额:
$ 7.65万 - 项目类别:
Task B03: Synthesis of a compound with activity against gram positive bacteria
任务 B03:具有抗革兰氏阳性菌活性的化合物的合成
- 批准号:
9916107 - 财政年份:2018
- 资助金额:
$ 7.65万 - 项目类别:
相似海外基金
Secure Smart Contracts with Isabelle/Solidity
使用 Isabelle/Solidity 保护智能合约
- 批准号:
EP/X027619/1 - 财政年份:2024
- 资助金额:
$ 7.65万 - 项目类别:
Research Grant
CSR: Small: Accelerating Data Intensive Scientific Workflows with Consistency Contracts
CSR:小:通过一致性合同加速数据密集型科学工作流程
- 批准号:
2317556 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Standard Grant
"i-agree": An innovative platform that provides confirmation of informed consent when making digital contracts preventing costly and lengthy disputes
“i-agree”:一个创新平台,在制定数字合同时提供知情同意确认,防止代价高昂且漫长的纠纷
- 批准号:
10075329 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Collaborative R&D
REQUEST TO ISSUE TASK ORDER 1 - TASK AREA 1: MANUAL OF OPERATIONS - FOR THE BRAIN INITIATIVE CELL ATLAS NETWORK (BICAN) SEQUENCING CORE CONTRACTS RFP 75N95022R00031 WITH THE UNIVERSITY OF WASHINGTON
请求发布任务令 1 - 任务领域 1:操作手册 - 大脑倡议细胞阿特拉斯网络 (BICAN) 与华盛顿大学的测序核心合同 RFP 75N95022R00031
- 批准号:
10931180 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
CAREER: Scalable Assurance via Verifiable Hardware-Software Contracts
职业:通过可验证的硬件软件合同提供可扩展的保证
- 批准号:
2236855 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Continuing Grant
Building Digital Infrastructure for Impact Bonds (Outcome-Based Contracts) for Community Sport and Cultural Organisations
为社区体育和文化组织的影响力债券(基于结果的合同)构建数字基础设施
- 批准号:
10071349 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Collaborative R&D
An innovative platform to reduce the risk of cyber attacks on smart contracts for all blockchains by minimising human effort and improving the efficacy of security testing.
一个创新平台,通过最大限度地减少人力并提高安全测试的效率,降低所有区块链智能合约遭受网络攻击的风险。
- 批准号:
10047308 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Collaborative R&D
Explaining legal contracts to SMEs through conversational AI trained on open sourced contracts
通过受开源合同训练的对话式人工智能向中小企业解释法律合同
- 批准号:
10060279 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Collaborative R&D
CRII: SaTC: Discerning the Upgradeability of Smart Contracts in Blockchains From a Security Perspective
CRII:SaTC:从安全角度辨别区块链智能合约的可升级性
- 批准号:
2245627 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Standard Grant
REQUEST TO ISSUE TASK ORDER 1 - TASK AREA 1: MANUAL OF OPERATIONS - FOR THE BRAIN INITIATIVE CELL ATLAS NETWORK (BICAN) SEQUENCING CORE CONTRACTS WITH THE BROAD INSTITUTE
请求发布任务令 1 - 任务领域 1:操作手册 - 大脑计划细胞阿特拉斯网络 (BICAN) 与布罗德研究所签订测序核心合同
- 批准号:
10931182 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别: